Literature DB >> 15211623

Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia.

Stanley Zammit1, Gaynor Jones, Susan J Jones, Nadine Norton, Robert D Sanders, Charis Milham, Geraldine M McCarthy, Lisa A Jones, Alastair G Cardno, Marion Gray, Kieran C Murphy, Michael C O'Donovan, Michael J Owen.   

Abstract

Some studies have reported associations between COMT and MAO genotypes and aggression, though results have been inconsistent. We examined the relationship between Overt aggression scale (OAS) scores, and both MAOA and MAOB polymorphisms in a well-powered sample of 346 subjects with schizophrenia. We also examined COMT in a Stage II replication sample of 150 individuals, and combined these results with our previously reported (Stage I) findings for COMT. We found no evidence of any associations between OAS ratings and any of the polymorphisms investigated under different genetic models. There was no evidence of epistatic interaction between MAOA and COMT on OAS scores. These results fail to support the theory that functional polymorphisms within the MAOA, MAOB, or COMT genes, as determinants of catecholamine enzymatic activity, are risk factors for aggressive behavior. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211623     DOI: 10.1002/ajmg.b.30021

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  25 in total

1.  Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression.

Authors:  Stephen D Ginsberg; Shaoli Che; Audrey Hashim; Jiri Zavadil; Robert Cancro; Sang H Lee; Eva Petkova; Henry W Sershen; Jan Volavka
Journal:  Brain Struct Funct       Date:  2011-04-22       Impact factor: 3.270

Review 2.  Stress, genes and the biology of suicidal behavior.

Authors:  Dianne Currier; J John Mann
Journal:  Psychiatr Clin North Am       Date:  2008-06

3.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

4.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

Review 5.  Pathways to aggression in schizophrenia affect results of treatment.

Authors:  Jan Volavka; Leslie Citrome
Journal:  Schizophr Bull       Date:  2011-05-11       Impact factor: 9.306

Review 6.  Neurobiology of aggression and violence in schizophrenia.

Authors:  Michael Soyka
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

7.  The COMT Met158 allele and violence in schizophrenia: a meta-analysis.

Authors:  Savita G Bhakta; Jian-Ping Zhang; Anil K Malhotra
Journal:  Schizophr Res       Date:  2012-07-10       Impact factor: 4.939

8.  No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders.

Authors:  Gil Zalsman; Yung-yu Huang; Maria A Oquendo; David A Brent; Lucas Giner; Fatemeh Haghighi; Ainsley K Burke; Steven P Ellis; Dianne Currier; J John Mann
Journal:  Arch Suicide Res       Date:  2008

9.  Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features.

Authors:  Sarah E Bergen; Ayman H Fanous; Dermot Walsh; F Anthony O'Neill; Kenneth S Kendler
Journal:  Schizophr Res       Date:  2009-03-05       Impact factor: 4.939

10.  Association study between monoamine oxidase A (MAOA) gene polymorphisms and schizophrenia: lack of association with schizophrenia and possible association with affective disturbances of schizophrenia.

Authors:  Su Kang Kim; Hae Jeong Park; Hosik Seok; Hye Sook Jeon; Joo-Ho Chung; Won Sub Kang; Jong Woo Kim; Gyeong Im Yu; Dong Hoon Shin
Journal:  Mol Biol Rep       Date:  2014-02-09       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.